Support our 2023 Cycle for Survival Team
$100,000
Let's team up to accelerate progress in
rare cancer research
Let's team up to accelerate progress in rare cancer research
Cycle for Survival is an annual fundraiser to end rare cancers.
Cycle for Survival has raised more than $324 million dollars for rare cancer research and lifesaving clinical trials at Memorial Sloan Kettering (MSK), a world leader in cancer research, care, and education. 100% of every dollar raised by Cycle for Survival riders and donors goes directly to MSK doctors and scientists, fueling bold ideas and breakthroughs.
Our foundation is matching the first $10,000 raised by each of our regional JEDIs for Survival teams.
Donate today and we’ll double your support. $100,000 for rare cancer research at MSK is our GOAL.
Meet our JEDI Captains
Join our mission to save lives! If you have questions or would like to create your own JEDIs for Survival team, contact Co-Captain Alex Wolin at Alex@jedicancerfoundation.org
Ride Date & Time: Saturday, April 29 | 1pm – 5pm • Ride Location: Outdoors at Wollman Rink in Central Park
JEDI Family
and Friends
Ride Date: Saturday, April 29
JEDI Captains: Mark Taxel
Location: New York, NY
Password: jedifamilyfriends
JEDI
Cyclemasters
JEDI Captain: Tiffany Taxel
Location: New York, NY
Password: ttaxJEDI2022
JEDI
Warriors
Ride Date: Saturday, April 29
JEDI Captain: Alex Wolin
Location: New York, NY
Password: 2023
Positive Promo
for JEDI
Ride Date: Saturday, April 29
JEDI Captain: Mike Taxel
Location: New York, NY
Password: Positive15
DC
JEDIs
Ride Date: Saturday, April 29 | 8am – 12pm
JEDI Captain: Harmony Knutson
Location: Washington, DC
Password: cycle2023
WE’RE ALL JEDIs FOR SURVIVAL
Let's team up to accelerate progress in rare cancer research.
Rare cancers comprise approximately 25% of cancers diagnosed annually today, yet rare cancer patients and their families have little or no hope of positive outcomes.
The Jed Ian Taxel Foundation for Cancer Research and programs like MSK’s annual Cycle for Survival fundraising event are committed to accelerating progress in rare cancer research, bringing new and better treatments to people around the world.
